219 related articles for article (PubMed ID: 29959420)
1. Osteopontin isoforms differentially promote arteriogenesis in response to ischemia via macrophage accumulation and survival.
Lee GS; Salazar HF; Joseph G; Lok ZSY; Caroti CM; Weiss D; Taylor WR; Lyle AN
Lab Invest; 2019 Mar; 99(3):331-345. PubMed ID: 29959420
[TBL] [Abstract][Full Text] [Related]
2. Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells.
Tilli TM; Mello KD; Ferreira LB; Matos AR; Accioly MT; Faria PA; Bellahcène A; Castronovo V; Gimba ER
Prostate; 2012 Nov; 72(15):1688-99. PubMed ID: 22495819
[TBL] [Abstract][Full Text] [Related]
3. Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer.
Goparaju CM; Pass HI; Blasberg JD; Hirsch N; Donington JS
J Thorac Oncol; 2010 Oct; 5(10):1516-23. PubMed ID: 20689445
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma.
Lin J; Myers AL; Wang Z; Nancarrow DJ; Ferrer-Torres D; Handlogten A; Leverenz K; Bao J; Thomas DG; Wang TD; Orringer MB; Reddy RM; Chang AC; Beer DG; Lin L
Oncotarget; 2015 Sep; 6(26):22239-57. PubMed ID: 26068949
[TBL] [Abstract][Full Text] [Related]
5. The role of osteopontin in recovery from hind limb ischemia.
Duvall CL; Weiss D; Robinson ST; Alameddine FM; Guldberg RE; Taylor WR
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):290-5. PubMed ID: 18006856
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin-c splicing isoform contributes to ovarian cancer progression.
Tilli TM; Franco VF; Robbs BK; Wanderley JL; da Silva FR; de Mello KD; Viola JP; Weber GF; Gimba ER
Mol Cancer Res; 2011 Mar; 9(3):280-93. PubMed ID: 21263033
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species regulate osteopontin expression in a murine model of postischemic neovascularization.
Lyle AN; Joseph G; Fan AE; Weiss D; Landázuri N; Taylor WR
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1383-91. PubMed ID: 22492090
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin (OPN) isoforms, diabetes, obesity, and cancer; what is one got to do with the other? A new role for OPN.
Sarosiek K; Jones E; Chipitsyna G; Al-Zoubi M; Kang C; Saxena S; Gandhi AV; Sendiky J; Yeo CJ; Arafat HA
J Gastrointest Surg; 2015 Apr; 19(4):639-50. PubMed ID: 25583441
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity.
Blasberg JD; Goparaju CM; Pass HI; Donington JS
J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1587-93. PubMed ID: 19818970
[TBL] [Abstract][Full Text] [Related]
10. P2Y2 nucleotide receptor mediates arteriogenesis in a murine model of hind limb ischemia.
McEnaney RM; Shukla A; Madigan MC; Sachdev U; Tzeng E
J Vasc Surg; 2016 Jan; 63(1):216-25. PubMed ID: 25088742
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells.
Nakamura KD; Tilli TM; Wanderley JL; Palumbo A; Mattos RM; Ferreira AC; Klumb CE; Nasciutti LE; Gimba ER
Tumour Biol; 2016 Feb; 37(2):2655-63. PubMed ID: 26404131
[TBL] [Abstract][Full Text] [Related]
12. A MicroRNA93-Interferon Regulatory Factor-9-Immunoresponsive Gene-1-Itaconic Acid Pathway Modulates M2-Like Macrophage Polarization to Revascularize Ischemic Muscle.
Ganta VC; Choi MH; Kutateladze A; Fox TE; Farber CR; Annex BH
Circulation; 2017 Jun; 135(24):2403-2425. PubMed ID: 28356443
[TBL] [Abstract][Full Text] [Related]
13. Changes in the transcriptional profile in response to overexpression of the osteopontin-c splice isoform in ovarian (OvCar-3) and prostate (PC-3) cancer cell lines.
Tilli TM; Bellahcène A; Castronovo V; Gimba ER
BMC Cancer; 2014 Jun; 14():433. PubMed ID: 24928374
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin and splice variant expression level in human malignant glioma: radiobiologic effects and prognosis after radiotherapy.
Güttler A; Giebler M; Cuno P; Wichmann H; Keßler J; Ostheimer C; Söling A; Strauss C; Illert J; Kappler M; Vordermark D; Bache M
Radiother Oncol; 2013 Sep; 108(3):535-40. PubMed ID: 23891093
[TBL] [Abstract][Full Text] [Related]
15. Expression pattern of osteopontin isoforms in malignant melanoma cell lines.
Koroknai V; Szász I; Jámbor K; Balázs M
Clin Transl Sci; 2024 Jan; 17(1):e13694. PubMed ID: 38058256
[TBL] [Abstract][Full Text] [Related]
16. Expression and regulation of nicotine receptor and osteopontin isoforms in human pancreatic ductal adenocarcinoma.
Sullivan J; Blair L; Alnajar A; Aziz T; Chipitsyna G; Gong Q; Yeo CJ; Arafat HA
Histol Histopathol; 2011 Jul; 26(7):893-904. PubMed ID: 21630219
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior.
Ferreira LB; Tavares C; Pestana A; Pereira CL; Eloy C; Pinto MT; Castro P; Batista R; Rios E; Sobrinho-Simões M; Gimba ER; Soares P
Oncotarget; 2016 Aug; 7(32):52003-52016. PubMed ID: 27409830
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease.
Vaughan EE; Liew A; Mashayekhi K; Dockery P; McDermott J; Kealy B; Flynn A; Duffy A; Coleman C; O'Regan A; Barry FP; O'Brien T
Cell Transplant; 2012; 21(6):1095-107. PubMed ID: 22304991
[TBL] [Abstract][Full Text] [Related]
19. AMP-Activated Protein Kinase α1 in Macrophages Promotes Collateral Remodeling and Arteriogenesis in Mice In Vivo.
Zhu H; Zhang M; Liu Z; Xing J; Moriasi C; Dai X; Zou MH
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1868-78. PubMed ID: 27444205
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin in Vascular Disease.
Lok ZSY; Lyle AN
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):613-622. PubMed ID: 30727754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
